DarioHealth Corp (OQ:DRIO)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 322 W 57Th St. #33B
NEW YORK NY 10019
Tel: N/A
Website: https://shop.mydario.com
IR: See website
<
Key People
Richard Allan Anderson
President
Erez Raphael
Chief Executive Officer, Director
Zvi Ben-David
Chief Financial Officer, Treasurer, Secretary
Tomer Ben-Kiki
Chief Operating Officer
   
Business Overview
DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Financial Overview
For the fiscal year ended 31 December 2023, DarioHealth Corp revenues decreased 26% to $20.4M. Net loss applicable to common stockholders decreased 1% to $63.5M. Revenues reflect Services decrease of 27% to $13.1M, Hardware and consumable products decrease of 26% to $7.3M. Lower net loss reflects Marketing and Pre-Production Cost decrease of 29% to $17.3M (expense), Interest Exp-Net of Capitalized Interest decrease from $1.9M (expense) to $0K.
Employees: 276 as of Mar 22, 2024
Reporting Currency: U.S. Dollars
Enterprise value: $25.61M as of Dec 31, 2023
Annual revenue (TTM): $20.35M as of Dec 31, 2023
EBITDA (TTM): -$51.08M as of Dec 31, 2023
Net annual income (TTM): -$63.51M as of Dec 31, 2023
Free cash flow (TTM): -$30.96M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 29,442,532 as of Mar 22, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.